Aarey Drugs, a company in the Pharmaceuticals industry, reported revenue of ₹89 crore and net profit of ₹1.37 crore for the September 2026 quarter.
Aarey Drugs (NSE: AAREYDRUGS) closed at ₹116.03 on 20 Nov 2026. Its market capitalisation is ₹370 crore and it trades at 81.8 times earnings.
Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverse industrial applications
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.